First Case Report of Acquired Pure Red Cell Aplasia Associated with Micafungin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

First Case Report of Acquired Pure Red Cell Aplasia Associated with Micafungin

Published:2011 Issue:9 Volume:50 Page:1051-1054
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Yoshida-Hiroi Mayumi¹,Koizumi Masayuki¹,Oka Reiko¹,Mitsuda Aki²,Hiroi Naoki³

Affiliation:

1. Department of Internal Medicine, Kawasaki Social Insurance Hospital, Japan

2. Department of Pathology, Kawasaki Social Insurance Hospital, Japan

3. Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine (Omori), Toho University School of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

http://www.jstage.jst.go.jp/article/internalmedicine/50/9/50_9_1051/_pdf

Reference21 articles.

1. In Vitro Activities of a New Lipopeptide Antifungal Agent, FK463, against a Variety of Clinically Important Fungi

2. New Drugs and Novel Targets for Treatment of Invasive Fungal Infections in Patients with Cancer

3. Pharmacokinetics of Micafungin in Healthy Volunteers, Volunteers With Moderate Liver Disease, and Volunteers With Renal Dysfunction

4. Micafungin: A New Echinocandin Antifungal

5. 5. Astellas Pharma US. Mycamine (micafungin sodium) package insert. Deerfield, IL, 2005.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coagulation dysfunction events associated with echinocandins: a real-world study from FDA adverse event reporting system (FAERS) database;Thrombosis Journal;2024-08-23

2. Systematic Review of Systemic Corticosteroids for Treatment of Organizing Pneumonia;Open Respiratory Archives;2022-10

3. Self-limiting pregnancy-associated pure red cell aplasia developing in two consecutive pregnancies: case report and literature review;International Journal of Hematology;2019-12-09

4. Micafungin;Meyler's Side Effects of Drugs;2016

5. Antifungal drugs;A worldwide yearly survey of new data in adverse drug reactions and interactions;2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3